These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9412900)

  • 41. [Evolution of myocardial ischemia therapy: calcium antagonists and ACE-inhibitors].
    Ferrari R
    Cardiologia; 1994 Dec; 39(12 Suppl 1):203-6. PubMed ID: 7634268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Evolution of the market of calcium dihydropyridinic antagonists and their use in the treatment of chronic forms of ischemic heart disease].
    Strashnyĭ VV; Lysenko AF
    Lik Sprava; 2002; (5-6):16-20. PubMed ID: 12442510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Calcium inhibitors and myocardial ischemia].
    Thuillez C
    Therapie; 1993; 48 Spec No():671-6. PubMed ID: 8091353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Lipid peroxidation and antioxidant defense system in myocardial ischemia].
    Barsel' VA; Syrkin AL; Eliubaeva ID; Kogan IG; Vakhliaev VD; Aksiutina MS; Arkhipova TV; Shchedrina IS
    Dokl Akad Nauk; 1996 Dec; 351(5):706-8. PubMed ID: 9102090
    [No Abstract]   [Full Text] [Related]  

  • 45. Ischaemic left ventricular dysfunction: a preventable precursor of heart failure?
    Waller DG
    Eur J Clin Pharmacol; 1998 Feb; 53(6):379-88. PubMed ID: 9551697
    [No Abstract]   [Full Text] [Related]  

  • 46. [Therapeutic application of myocardial cytoprotection].
    Ribeiro C
    Rev Port Cardiol; 1994 Sep; 13(9):669-70. PubMed ID: 7818940
    [No Abstract]   [Full Text] [Related]  

  • 47. [Treatment of myocardial ischemia with reference to blood pressure values].
    Schneeweiss A; Wiegand V
    Cardiology; 1993; 82 Suppl 2():58-65. PubMed ID: 8100187
    [No Abstract]   [Full Text] [Related]  

  • 48. [The current concept of the use of calcium antagonists in cardiology. Resolution of the Academic Council of the A. L. Miasnikov Research Institute of Cardiology of the KNTs of the Russian Academy of Medical Sciences].
    Ter Arkh; 1996; 68(9):18-9. PubMed ID: 9005604
    [No Abstract]   [Full Text] [Related]  

  • 49. [Relationship between calcium overload and myocardial ischemia reperfusion injury and intervention strategy of Chinese herbal medicine].
    Li JP; Guo LL; Chen Z; Wang R; Wang J
    Zhongguo Zhong Yao Za Zhi; 2016 Jun; 41(11):2168-2173. PubMed ID: 28901117
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The clinical, hemodynamic and hormonal-metabolic effects of the calcium-antagonist treatment of middle-aged and elderly patients with IHD at the polyclinic stage of rehabilitation].
    Pimenov LT; Ezhov AV; Churshin AD; Dudarev MV
    Ter Arkh; 1996; 68(1):42-5. PubMed ID: 8644030
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Heart rate control: f-channel blockers].
    Kryzhanovskiĭ SA; Vititnova MB
    Fiziol Cheloveka; 2009; 35(2):112-23. PubMed ID: 19402561
    [No Abstract]   [Full Text] [Related]  

  • 52. Application of calcium channel blockers in the treatment of cardiovascular diseases.
    Herman ZS
    Pol J Pharmacol; 1999; 51(2):201-6. PubMed ID: 10425650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of nitrates, calcium channel blockers and ACE inhibitors in primary care in the Northern Region: a pharmacoepidemiological study.
    Roberts SJ; Bateman DN
    Br J Clin Pharmacol; 1994 Dec; 38(6):489-97. PubMed ID: 7888286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Left ventricular diastolic dysfunction in ischemic heart disease. Effects of drug therapy].
    Witkowska M
    Kardiol Pol; 1992 Dec; 37(12):399-403. PubMed ID: 1363437
    [No Abstract]   [Full Text] [Related]  

  • 55. Ischemic heart disease: bridging the gap between theory and practice.
    Warnica JW
    Can J Cardiol; 1995 Apr; 11 Suppl B():4B. PubMed ID: 7728650
    [No Abstract]   [Full Text] [Related]  

  • 56. [Silent myocardial ischemia. Arguments in favor of treatment].
    Lezaun R; Maraví C; Gervás H; Madariaga I; Basterra N; de los Arcos E
    Rev Esp Cardiol; 1996 Jan; 49(1):1-5. PubMed ID: 8685506
    [No Abstract]   [Full Text] [Related]  

  • 57. [Indications for calcium channel antagonist therapy according to the latest large clinical trials].
    Kosicka T; Kara-Perz H; Głuszek J; Perz S
    Pol Arch Med Wewn; 2005 Dec; 114(6):1244-51. PubMed ID: 16789496
    [No Abstract]   [Full Text] [Related]  

  • 58. Reduction of ischemia during off-pump coronary artery bypass graft surgery.
    Kwak YL
    J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):667-77. PubMed ID: 16202908
    [No Abstract]   [Full Text] [Related]  

  • 59. Does diltiazem inhibit the inflammatory response in cardiopulmonary bypass?
    Fansa I; Gol M; Nisanoglu V; Yavas S; Iscan Z; Tasdemir O
    Med Sci Monit; 2003 Apr; 9(4):PI30-6. PubMed ID: 12709682
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The experimental study of myocardial protection for warm myocardial ischemia in an isolated rat heart: the effect of a calcium antagonist].
    Fukuhiro Y
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Feb; 44(2):130-7. PubMed ID: 8717259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.